2012
DOI: 10.1097/pas.0b013e31824e9b7c
|View full text |Cite
|
Sign up to set email alerts
|

Role of Foxp3-positive Tumor-infiltrating Lymphocytes in the Histologic Features and Clinical Outcomes of Hepatocellular Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
42
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(45 citation statements)
references
References 33 publications
2
42
1
Order By: Relevance
“…An intra-epithelial location of CTLs could possibly mean a more effective protection in that aspect. Tregs have been known to counteract the anti-tumour immune response in some cancers (Deschoolmeester et al , 2011; Mathai et al , 2012), but its role cannot be assessed as unambiguous as we still cannot see the whole picture. In this study, a high infiltration of FOXP3 + cells seems to be a protective factor, associated with a very good patient outcome, whereas the reverse can be said for patients with a very low infiltration, results that are consistent with the works of Salama et al (2009), Ladoire et al (2011b) and Frey et al (2010).…”
Section: Discussionmentioning
confidence: 99%
“…An intra-epithelial location of CTLs could possibly mean a more effective protection in that aspect. Tregs have been known to counteract the anti-tumour immune response in some cancers (Deschoolmeester et al , 2011; Mathai et al , 2012), but its role cannot be assessed as unambiguous as we still cannot see the whole picture. In this study, a high infiltration of FOXP3 + cells seems to be a protective factor, associated with a very good patient outcome, whereas the reverse can be said for patients with a very low infiltration, results that are consistent with the works of Salama et al (2009), Ladoire et al (2011b) and Frey et al (2010).…”
Section: Discussionmentioning
confidence: 99%
“…Increased levels of CD4+ CD25+ Tregs have been reported in peripheral blood and the tumor microenvironment of patients with non–small cell lung carcinoma [89], gastrointestinal malignancies [90], ovarian cancer [91], SCC of the head and neck [92], hepatocellular carcinoma [93], breast cancer, pancreatic cancer [94] and prostate carcinoma [95]. Tregs variably present within the tumor microenvironment [96].…”
Section: Immune Cells With Pro-tumor Functionsmentioning
confidence: 99%
“…Our search strategy yielded 573 primary articles, of which 16 were eventually identified fulfilling the eligibility criteria (Fu et al, 2007;Gao et al, 2007;Kobayashi et al, 2007;Sasaki et al, 2008;Cai et al, 2009;Ju et al, 2009a;2009b;Zhou et al, 2009;2010;Chen et al, 2011;Shen et al, 2011;Huang et al, 2012;Mathai et al, 2012;Wang et al, 2012;Lin et al, 2013) (Fig. 1).…”
Section: Study Characteristicsmentioning
confidence: 99%